31 results
Page 2 of 2
8-K
EX-99.1
zrcch j3u3
14 Mar 13
Ligand Signs Global License Agreement with Spectrum Pharmaceuticals for Captisol-Enabled® Melphalan
12:00am
8-K
EX-99.1
hjlc24da
13 Feb 13
Ligand Reports Fourth Quarter and Full Year 2012 Financial Results
12:00am
8-K
EX-99.1
tvpjrj ijzv0njgmsiv
14 Dec 12
Other Events
12:00am
8-K
EX-99.2
uea apcrahyvjmr59lq
4 Dec 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
h4mm x23gabuivn
4 Dec 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ulwww8jpx3hj9
19 Nov 12
Other Events
12:00am
8-K
EX-99.1
ixo35b61 jaf0oul80
5 Nov 12
Ligand Pharmaceuticals Reports Preliminary Third Quarter 2012 Results
12:00am
8-K
EX-99.1
5ut71tubk8h9q8j
5 Nov 12
Ligand Pharmaceuticals to Restate Previous Financial Statements
12:00am
8-K
EX-99.1
hxz4r6v653j5k
22 Oct 12
Ligand to Receive $2 Million Milestone Payment from Merck Triggered by Initiation of Phase 2b/3 Trial of Dinaciclib
12:00am
425
izn4sqj
31 Aug 09
Business combination disclosure
12:00am